Harnessing Online Peer Education (HOPE) Social Media Intervention for Chronic Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Chronic Pain+1 More
Harnessing Online Peer Education (HOPE) Social Media Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether using social media to deliver a psychological intervention can reduce prescription drug abuse among patients with chronic pain.

Eligible Conditions
  • Chronic Pain
  • Pain

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 3 months

3 months
Reduction in Current Opioid Misuse Measure (COMM) Score

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

control
1 of 2
intervention
1 of 2
Active Control
Experimental Treatment

51 Total Participants · 2 Treatment Groups

Primary Treatment: Harnessing Online Peer Education (HOPE) Social Media Intervention · No Placebo Group · N/A

intervention
Behavioral
Experimental Group · 1 Intervention: Harnessing Online Peer Education (HOPE) Social Media Intervention · Intervention Types: Behavioral
controlNoIntervention Group · 1 Intervention: control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,404 Previous Clinical Trials
6,942,396 Total Patients Enrolled
7 Trials studying Chronic Pain
5,730 Patients Enrolled for Chronic Pain

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are on chronic opioid therapy for chronic non-cancer pain.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 4th, 2021

Last Reviewed: October 18th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.